The Orphan Drug Tax Credit is critical to continued innovation in rare disease drug development. Recent proposals considered by Congress threaten to limit the applicability of the incentive, which was previously halved in 2017. Please help us protect the Orphan Drug Tax...

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer programs (STTR) provide essential federal grant funding to small businesses and startups to develop and bring new products to market. They have supported scientific and technological...

The Farm Bill is a critical piece of legislation that supports the U.S. agricultural economy and must be renewed by the end of this year. The bill has a 5-year cycle and, over its history, has been invaluable and enabled innovation in the fields of cellular and plant-based...

After battling the COVID-19 pandemic, the United States needs a plan and the tools to prepare for the next outbreak. The Pandemic and All-Hazards Preparedness Act (PAHPA) is a piece of legislation that authorizes critical agencies and programs that are on the front line of...

Rare pediatric diseases are an area with extreme unmet need in our health care ecosystem. The challenges associated with rare diseases, such as small populations, unknown cause and/or course of the disease, and widely dispersed patient populations, are exacerbated in...